- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.11. | MANGOCEUTICALS, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 14.11. | Eli Lilly and Novo Nordisk disown Mangoceuticals' GLP-1RA partnership claim | 39 | Pharmaceutical Technology | ||
| 14.11. | Mangoceuticals plunges after denying Lilly, Novo partnerships | 22 | Seeking Alpha | ||
| 14.11. | Mangoceuticals, Inc.: Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs | 2.119 | GlobeNewswire (Europe) | Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company") is issuing the following clarification regarding its press release issued earlier... ► Artikel lesen | |
| 13.11. | Lilly, Novo shoot down claims of DTC obesity drug partnership with Mangoceuticals | 39 | FiercePharma | ||
| 13.11. | Mangoceuticals: Aktie stürzt nach Dementi von Novo Nordisk und Eli Lilly ab | 53 | Investing.com Deutsch | ||
| 13.11. | Lilly, Novo in pact with Mangoceuticals for direct sales of weight loss drugs | 50 | Seeking Alpha | ||
| 13.11. | Mangoceuticals launches direct GLP-1 medication access programs | 21 | Investing.com | ||
| MANGOCEUTICALS Aktie jetzt für 0€ handeln | |||||
| 13.11. | MANGOCEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 12.09. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.09. | MANGOCEUTICALS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 04.08. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.07. | Mangoceuticals emittiert 6 % konvertierbare Vorzugsaktien der Serie B | 1 | Investing.com Deutsch | ||
| 03.07. | Mangoceuticals-Präsident Tony Isaac tritt von Vorstands- und Führungsposition zurück | 2 | Investing.com Deutsch | ||
| 03.07. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.06. | Mangoceuticals files $150M mixed securities shelf | 1 | Seeking Alpha | ||
| 10.06. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.05. | Mangoceuticals, Inc.: Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu | 203 | GlobeNewswire (Europe) | Dallas, TX, May 27, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of health and... ► Artikel lesen | |
| 26.04. | ArcStone US Corp.: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into th | 1.225 | Newsfile | New York, New York and Dallas, Texas--(Newsfile Corp. - April 26, 2025) - ArcStone Securities and Investments Corp. ("ArcStone"), a cross-border financial services firm, is pleased to announce its role... ► Artikel lesen | |
| 25.04. | Mangoceuticals, Inc.: Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch ... | 385 | GlobeNewswire (Europe) | DALLAS, TX, April 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals Inc. (NASDAQ: MGRX) ("Mangoceuticals" or "MGRX"), a company focused on developing, marketing, and selling a variety of health and wellness... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SPINEWAY | 0,146 | -7,69 % | Spineway: Revenue growth in the third quarter | Ecully, October 14, 2025 - 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| NUWELLIS, INC | 2,430 | -7,60 % | Nuwellis erweitert pädiatrische Präsenz durch Einsatz in führender US-Kinderklinik | ||
| LOGICMARK | - | - | LogicMark, Inc. Announces Third Quarter 2025 Results | LOUISVILLE, Ky., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc.?(OTC: LGMKD) (the Company), a provider of personal safety and emergency response systems (PERS), health communications devices, and... ► Artikel lesen | |
| NANOVIBRONIX | 4,110 | +0,49 % | NanoVibronix, Inc. - 8-K, Current Report | ||
| SIEMENS HEALTHINEERS | 43,510 | +1,92 % | EQS-PVR: Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Siemens Healthineers AG
Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
01.12.2025 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,040 | +0,08 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,790 | +1,79 % | IPO Stock Of The Week: Health Care Leader BrightSpring Falls Back Into Buying Range | ||
| PROCEPT BIOROBOTICS | 35,860 | +1,21 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| FRESENIUS | 47,720 | -0,60 % | Fresenius-Aktie: Kaufen! | Die Aktie des Gesundheitskonzerns Fresenius hat sich in den zurückliegenden Wochen doch wieder spürbar von den Mehrjahreshochs Ende Oktober entfernt. An den mittel- bis langfristigen Aussichten für... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,550 | +0,77 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROGYNY | 24,020 | -0,54 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GENEDX | 158,96 | -1,85 % | Cathie Wood's ARK sells Iridium, buys GeneDx and WeRide stock | ||
| BETA BIONICS | 29,380 | -2,07 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| NUTEX HEALTH | 160,95 | +2,65 % | Nutex Health extends share repurchase plan |
MANGOCEUTICALS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -6,78 % bei einem Aktienkurs von 1,100 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MANGOCEUTICALS INC finden Sie auf Wallstreet Online.